SHIFT: Studying HIV Immunology After Fecal Transplant

Summary

SHIFT is a randomized, longitudinal, prospective, blinded, three-arm study to determine the safety and tolerability of Fecal Microbiota Transplant (FMT) in HIV-infected participants on stable antiretroviral therapy (ART).

Timeline

Start

2018-06

Primary completion

2020-06

Completion

2022-06

Outcome

Outcome not reported

Stopped: “The study closed because of shifting research priorities and interests.”

Drugs

Indications